Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Savicell Diagnostics' primary product?
- Savicell Diagnostics develops the Well-Shield platform, a blood test designed for the early detection of disease, with a focus on cancer.
- When was Savicell Diagnostics founded?
- Savicell Diagnostics was founded in April 2012.
- What is the current employee count for Savicell Diagnostics?
- Savicell Diagnostics currently has 8 employees.
- What is the current funding stage of Savicell Diagnostics?
- Savicell Diagnostics is currently in the Pre-Funding stage.
- What was a significant collaboration for Savicell Diagnostics in August 2021?
- In August 2021, Orgenesis announced a collaboration with Savicell Diagnostics on its ImmunoBiopsy platform.
- What type of technology does Savicell Diagnostics utilize for its Well-Shield platform?
- The Well-Shield technology is designed to detect and interpret differential metabolic responses that can indicate disease intrusion and cell malformation, including cancer.
- Where is Savicell Diagnostics headquartered?
- Savicell Diagnostics is headquartered in Haifa, Israel.
- What was reported about Savicell Diagnostics' blood test for lung cancer in July 2019?
- In July 2019, news sources reported on Savicell Diagnostics' revolutionary blood test designed to detect stage 1 lung cancer.